XML 57 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Shareholders' Equity (Tables)
6 Months Ended
Mar. 31, 2013
Equity [Abstract]  
Schedule Of Share-Based Compensation Expense Categories
                           
    Three months Ended
March 31,
  Six months Ended
March 31,
 
    2013   2012   2013   2012  
    (in thousands)  
Sales and marketing   $ 469   $ 109   $ 928   $ 200  
Engineering and product development     21     6     43     8  
General and administrative     95     70     191     125  
Total   $ 585   $ 185   $ 1,162   $ 333  
Summary Of The Company's Stock Option Plans
                           
    Number of
Options
Outstanding
  Weighted-
Average
Exercise
Price
  Weighted-
Average
Remaining
Contractual
Term
  Aggregate
Intrinsic
Value $(000)
 
                           
Outstanding, October 1, 2012     355,334   $ 3.71              
                           
Granted                      
Canceled                      
Exercised     (45,000 )   2.95              
Outstanding, March 31, 2013     310,334  

$

 

3.82

 

   

4.07

 

 

$

 

3,468

 

 
                           
Vested or expected to vest, March 31, 2013     302,578  

$

 

3.82

 

   

3.97

 

 

$

 

3,383

 

 
                           
Exercisable, March 31, 2013     232,770  

$

 

3.77

 

   

3.68

 

 

$

 

2,615

 

 
Schedule of market prices per share on a national securities exchange
         
    Number of
Unvested
RSUs
 
         
$10.00 per share prior to the fifth anniversary of the grant date     149,676  
$10.00 per share prior to the fourth anniversary of the grant date     191,573  
$17.50 per share prior to the fourth anniversary of the grant date     136,000  
$20.00 per share prior to the fourth anniversary of the grant date     8,500  
$22.50 per share prior to the fourth anniversary of the grant date     19,000  
No vesting condition     29,170  
         
Unvested RSUs, March 31, 2013     533,919  
Schedule Of Restricted Stock Unit Information
         
    Number of
RSUs
Outstanding
 
         
Outstanding, October 1, 2012     464,584  
Granted     127,500  
Canceled      
Vested     (58,165 )
Outstanding, March 31, 2013     533,919